215
Views
11
CrossRef citations to date
0
Altmetric
Research Article

'Missed' Micrometastases: The Extent of the Problem

&
Pages 313-317 | Published online: 08 Jul 2009

References

  • Hainsworth PJ, Tjandra JJ, Stillwell RG, et al. Detection and significance of occult metastases in node negative breast can-cer. Br J Surg 1993; 80: 459–63.
  • Carter CL, Allen C, Henson DE. Relation of tumour size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989; 63: 181–7.
  • Wilking N, Rutqvist LE, Mattsson A, et al. Prognostic signifi-cance of axillary nodal status in primary breast cancer in relation to the number of resected nodes. Acta Oncol 1992; 31: 29–35.
  • Aaltomaa S, Lipponen P, Eskelinen M, et al. Prognostic factors after 5 years follow-up in female breast cancer. Oncol-ogy 1992; 49: 93–8.
  • Fisher B, Bauer M, Wickenham L, et al. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. Cancer 1983; 52: 1551–7.
  • Fisher ER, Swamidoss S, Lee CH, et al. Detection and significance of occult axillary node metastases in patients with invasive cancer. Cancer 1978; 42: 2025–31.
  • International (Ludwig) Breast Cancer Study Group. Prognos-tic importance of occult axillary lymph node micrometastases from breast cancer. Lancet 1990; 335: 1565–68.
  • Friedman S, Bertin F, Mouriesse H, et al. Importance of tumor cells in axillary node sinus margins (`Clandestine' metastases) discovered by serial sectioning in operable breast carcinoma. Acta Oncol 1988; 27: 483–7.
  • Munro NA. Are breast cancer axillary node micrometastases worth detecting? J Pathol 1990; 161: 283–4.
  • Hartveit F, Lilleng PK. Breast cancer: two micrometastatic variants in the axilla that differ in prognosis. Histopathology 1996; 28: 241–6.
  • Lilleng PK, Mwhle BO, Hartveit F. The size of a micrometas-tasis in the axilla in breast cancer: a study of nodal tumour-load related to prognosis. Eur J Gynaecol Oncol 1998; 3: 220–4.
  • Lilleng PK, Hartveit F. Staging nodal growth in breast cancer on a histological basis. Eur J Gynaecol Oncol 1998; 3: 249–252.
  • Trojani M, de Mascarel I, Bonichon F, et al. Micrometastases to axillary lymph nodes from carcinoma of breast: detection by immunohistochemistry and prognostic significance. Br J Cancer 1987; 55: 303–6.
  • Wells CA, Heryet A, Brochier J, et al. The immunocytochem-ical detection of axillary micrometastases in breast cancer. Br J Cancer 1984; 50: 193–7.
  • Hartveit F. The routine histological investigation of axillary lymph nodes for metastatic breast cancer. J Pathol 1984; 143: 187 —91.
  • Hartveit F, Tangen M, Halvorsen JF, et al. Time dependent changes in the axillary nodes in breast cancer: nodal area. Oncology 1985; 24: 210–6.
  • Azzopardi JG. Problems in breast pathology. London: WB Saunders Co. Ltd, 1979: 242–80.
  • Linell F, Rank F. Breast cancer. Comments on histological classifications with reference to histogenesis and prognosis. Dialogos 1989; 35–7.
  • de Mascarel I, Bonichon F, Coindre JM, et al. Prognostic significance of breast cancer axillary lymph node micrometas-tases assessed by two special techniques: reevaluation with longer follow-up. Br J Cancer 1992; 66: 523–7.
  • Fisher CJ, Hill S, Millis RR. Benign lymph node inclusions mimicking metastatic carcinoma. J Clin Pathol 1994; 47: 868–9.
  • Hartveit F, Lilleng PK. Missed nodal metastases in breast cancer. Int J Oncol 1994; 4: 873–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.